9-122750466-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004453.3(OR1L6):c.619G>A(p.Val207Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,502,114 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004453.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR1L6 | NM_001004453.3 | c.619G>A | p.Val207Ile | missense_variant | 2/2 | ENST00000304720.3 | NP_001004453.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR1L6 | ENST00000304720.3 | c.619G>A | p.Val207Ile | missense_variant | 2/2 | NM_001004453.3 | ENSP00000304235 | P1 | ||
OR1L6 | ENST00000373684.1 | c.727G>A | p.Val243Ile | missense_variant | 1/1 | ENSP00000362788 |
Frequencies
GnomAD3 genomes AF: 0.0000435 AC: 6AN: 137834Hom.: 0 Cov.: 20
GnomAD3 exomes AF: 0.0000124 AC: 3AN: 241582Hom.: 0 AF XY: 0.0000153 AC XY: 2AN XY: 130338
GnomAD4 exome AF: 0.0000257 AC: 35AN: 1364160Hom.: 1 Cov.: 26 AF XY: 0.0000249 AC XY: 17AN XY: 682450
GnomAD4 genome AF: 0.0000435 AC: 6AN: 137954Hom.: 0 Cov.: 20 AF XY: 0.0000603 AC XY: 4AN XY: 66346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.619G>A (p.V207I) alteration is located in exon 1 (coding exon 1) of the OR1L6 gene. This alteration results from a G to A substitution at nucleotide position 619, causing the valine (V) at amino acid position 207 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at